121 related articles for article (PubMed ID: 4329940)
1. Hyperresponsiveness to tolbutamide of dogs pretreated with diazoxide.
Anderson JH; Byrd GW; Blackard WG
Metabolism; 1971 Nov; 20(11):1023-30. PubMed ID: 4329940
[No Abstract] [Full Text] [Related]
2. Insulin secretion studied in the perfused rat pancreas. I. Effect of tolbutamide, leucine and arginine; their interaction with diazoxide, and relation to glucose.
Basabe JC; Lopez NL; Viktora JK; Wolff FW
Diabetes; 1971 Jul; 20(7):449-56. PubMed ID: 5556282
[No Abstract] [Full Text] [Related]
3. The use of diazoxide inhibition of insulin secretion as a tool to investigate insulin stimulation by other agents.
Gulbenkian A; Ornstein L; Tabachnick II
Horm Metab Res; 1972 Mar; 4(2):57-8. PubMed ID: 5028220
[No Abstract] [Full Text] [Related]
4. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.
Loubatières A; Mariani MM; Alric R
Ann N Y Acad Sci; 1968 Apr; 150(2):226-41. PubMed ID: 4875709
[No Abstract] [Full Text] [Related]
5. Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas.
Seltzer HS; Crout JR
Ann N Y Acad Sci; 1968 Apr; 150(2):309-21. PubMed ID: 4875710
[No Abstract] [Full Text] [Related]
6. Modulation of pancreatic somatostatin by adrenergic and cholinergic agonism and by hyper- and hypoglycemic sulfonamides.
Samols E; Weir GC; Ramseur R; Day JA; Patel YC
Metabolism; 1978 Sep; 27(9 Suppl 1):1219-21. PubMed ID: 682983
[No Abstract] [Full Text] [Related]
7. Interaction of various stimulators and inhibitors on insulin secretion in vitro.
Voyles N; Gutman RA; Selawry H; Fink G; Penhos JC; Recant L
Horm Res; 1973; 4(2):65-73. PubMed ID: 4355994
[No Abstract] [Full Text] [Related]
8. Reversible inhibition by hyaluronidase of the insulinotropic action of tolbutamide in isolated hamster pancreatic islets.
Macchi IA; Zeytinoğlu FN; Beaser SB
Proc Soc Exp Biol Med; 1974 Feb; 145(2):500-3. PubMed ID: 4360641
[No Abstract] [Full Text] [Related]
9. Insulinotropic effect and possible mode of action of a new potent sulfonylurea (BS-4231).
Brisson GR; Malaisse WJ
Can J Physiol Pharmacol; 1971 Jun; 49(6):536-44. PubMed ID: 4932540
[No Abstract] [Full Text] [Related]
10. [Effect of adrenergic blocking agents on the acute tolbutamide response in dogs].
Sirek A; Sirek OV; Smigura F; Przybylska K
Acta Diabetol Lat; 1970; 7(5):777-88. PubMed ID: 4404338
[No Abstract] [Full Text] [Related]
11. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
[No Abstract] [Full Text] [Related]
12. [Antagonistic effect of diazoxide and tolbutamide on the cardiovascular system].
Loubatiéres AL; Loubatiéres-Mariani MM; Ribes G; Chapal J
C R Seances Soc Biol Fil; 1972; 166(8):1042-6. PubMed ID: 4660168
[No Abstract] [Full Text] [Related]
13. Insulin secretion of the isolated perfused pancreas of the Chinese hamster (Cricetulus griseus).
Gerhards E; Rühl M
Acta Endocrinol (Copenh); 1974 Jun; 76(2):302-18. PubMed ID: 4406592
[No Abstract] [Full Text] [Related]
14. [Sulfonamides modifying insulin secretion and the development of the islands of Langerhans. Actions and antagonisms of actions. Some experimental studies of their clinical applications].
Loubatières A; Mariani MM; Alric R
Bull Acad Natl Med; 1967 Dec; 151(33):683-94. PubMed ID: 4866937
[No Abstract] [Full Text] [Related]
15. Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in beta-cells.
Mariot P; Gilon P; Nenquin M; Henquin JC
Diabetes; 1998 Mar; 47(3):365-73. PubMed ID: 9519741
[TBL] [Abstract][Full Text] [Related]
16. AO44: an improved hyperglycemic agent.
Lopez N; Basabe J; Grant A; Krees S; Terry M; Viktora J; Wolff F
Metabolism; 1971 Apr; 20(4):373-83. PubMed ID: 5550304
[No Abstract] [Full Text] [Related]
17. [Propranolol and hypoglycemic sulfonamides. Study on insulin secretion and blood sugar].
Loubathières A; Mariani MM; Ribes G; Chapal J
C R Seances Soc Biol Fil; 1971; 165(6):1393-7. PubMed ID: 4262051
[No Abstract] [Full Text] [Related]
18. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
Loubatiéres A; Mariani MM
Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
[No Abstract] [Full Text] [Related]
19. Effect of tolbutamide on blood pressure.
Wolff F; Grant A
N Engl J Med; 1971 Apr; 284(15):915-6. PubMed ID: 4994368
[No Abstract] [Full Text] [Related]
20. Differences in insulin release in response to glucose and tolbutamide stimulation.
Bennett LL; Curry DL; Curry K
Proc Soc Exp Biol Med; 1973 Nov; 144(2):436-9. PubMed ID: 4746913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
